发明名称 Opioid agonist antagonist combinations
摘要 The invention relates a composition comprising an opioid agonist and Compound-1:;
申请公布号 US9211293(B2) 申请公布日期 2015.12.15
申请号 US201213717128 申请日期 2012.12.17
申请人 Alkermes Pharma Ireland Limited 发明人 Deaver Daniel;Ehrich Elliot
分类号 A61K31/485;A61K45/06 主分类号 A61K31/485
代理机构 Elmore Patent Law Group, P.C. 代理人 Elmore Carolyn S.;Issac Roy P.;Elmore Patent Law Group, P.C.
主权项 1. A composition comprising a pharmaceutically effective amount of an opioid agonist and Compound-1: wherein said opioid agonist is selected from the group consisting of alfentanil, allylprodine, alphaprodine, anileridine, benzylmorphine, bezitramide, brifentanil, carfentanil, clonitazene, codeine, dextromoramide, desomorphine, diampromide, diamorphone, dihydrocodeine, dihydromorphine, dimenoxadol, dimepheptanol, dimethylthiambutene, dioxaphetyl butyrate, dipipanone, eptazocine, ethoheptazine, ethylmethylthiambutene, ethylmorphine, etonitazene, etorphine, fentanyl, heroin, hydrocodone, hydrocodone, hydromorphone, hydroxypethidine, isomethadone, ketobemidone, levorphanol, levallorphan, levomethadone, levophenacylmorphan, lofentanil, meperidine (pethidine), metazocine, methadone, metopon, 4-methoxymethylfentanyl, 3-methylfentanil, mirfentanil, 6-monoacetylmorphine, morphine, morphine-6-glucuronide, ohmefentanyl, oxycodone, oxymorphone, propoxyphene, pentazocine, propiram, propoxyphene, racemorphan, sufentanil, tapentadol, tramadol and tilidine; and, wherein Compound-1:agonist has a molar ratio of about 0.5-1.75:1.0.
地址 Dublin IE